Tap to Call
Tap to Begin
Live Chat


Ready to Help Whenever You Need Us

We know who to talk to, where to find answers, and what steps you need to take. Let us put more than 40 years of experience to work for you.

Avandia Linked to Increased Risk of Heart Attack and Death

Avandia, a widely prescribed drug used to treat Type-2 diabetes, has been shown to increase users’ risk of heart attack by 43 percent and cardiac-related death by 64 percent, according to the 2007 study, Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.

Because of the public health importance of this study, the New England Journal of Medicine released an early online version of an article that appeared in its June 14, 2007 issue.

The study was conducted by two doctors at the Cleveland Clinic who evaluated 42 studies that compared patients taking Avandia with those who were not. The overall study involved 28,000 patients, 15,560 of whom were taking Avandia.

Of those patients taking Avandia, 86 suffered heart attacks compared to 72 among patients not on the drug. In addition, another 39 patients died from cardiovascular causes compared to 22 patients who were not taking Avandia.

If you or your loved one has suffered an Avandia injury, contact us today. Submit the form to the right and we’ll let you know if you have a case and if we can represent you.


Avandia was last modified: August 11th, 2017 by Sokolove Law